Our data further confirmed that continuous intrathecal injections of NFAT1 inhibitors suppressed tumor‐mediated bone cancer pain, indicating that NFAT1 plays an important role in the development and progression of bone cancer pain in male mice. This evidence concerns the gene NFATC2 and bone cancer.